Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats

被引:47
作者
Deguchi, T
Kouno, Y
Terasaki, T
Takadate, A
Otagiri, M [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan
[3] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808578, Japan
[4] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Saitama 3320012, Japan
[5] Daiichi Coll Pharmaceut Sci, Minami Ku, Fukuoka 8150037, Japan
关键词
chronic renal failure; kidney uptake index; nephrotoxicity; organic anion transporters; uremic toxins;
D O I
10.1007/s11095-005-2486-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Evidence suggests that uremic toxins such as hippurate ( HA), indoleacetate (IA), indoxyl sulfate ( IS), and 3-carboxy-4-methyl-5-propyl-2-furanpropionate ( CMPF) promote the progression of renal failure by damaging tubular cells via rat organic anion transporter 1 (rOat1) and rOat3 on the basolateral membrane of the proximal tubules. The purpose of the current study is to evaluate the in vivo transport mechanism responsible for their renal uptake. Methods. We investigated the uremic toxins transport mechanism using the abdominal aorta injection technique [i. e., kidney uptake index (KUI) method], assuming minimal mixing of the bolus with serum protein from circulating serum. Results. Maximum mixing was estimated to be 5.8% of rat serum by measuring estrone sulfate extraction after addition of 0 - 90% rat serum to the arterial injection solution. Saturable renal uptake of p-aminohippurate (PAH, K-m = 408 mu M) and benzylpenicillin (PCG, K-m = 346 mu M) was observed, respectively. The uptake of PAH and PCG was inhibited in a dose-dependent manner by unlabeled PCG (IC50 = 47.3 mM) and PAH (IC50 = 512 mu M), respectively, suggesting that different transporters are responsible for their uptake. A number of uremic toxins inhibited the renal uptake of PAH and PCG. Excess PAH, which could inhibit rOat1 and rOat3, completely inhibited the saturable uptake of IA, IS, and CMPF by the kidney, and by 85% for HA uptake. PCG inhibited the total saturable uptake of HA, IA, IS, and CMPF by 10%, 10%, 45%, and 65%, respectively, at the concentration selective for rOat3. Conclusions. rOat1 could be the primary mediator of the renal uptake of HA and IA, accounting for approximately 75% and 90% of their transport, respectively. rOat1 and rOat3 contributed equally to the renal uptake of IS. rOat3 could account for about 65% of the uptake of CMPF under in vivo physiologic conditions. These results suggest that rOat1 and rOat3 play an important role in the renal uptake of uremic toxins and the induction of their nephrotoxicity.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 30 条
  • [1] Aiba T, 1999, BIOL PHARM BULL, V22, P633
  • [2] Transport of organic anions across the basolateral membrane of proximal tubule cells
    Burckhardt, BC
    Burckhardt, G
    [J]. REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 : 95 - 158
  • [3] SELECTIVE AVAILABILITY OF PROTEIN-BOUND ESTROGEN AND ESTROGEN CONJUGATES TO THE RAT-KIDNEY
    CHAUDHURI, G
    VERHEUGEN, C
    PARDRIDGE, WM
    JUDD, HL
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (03) : 283 - 290
  • [4] Characterization of uremic toxin transport by organic anion transporters in the kidney
    Deguchi, T
    Kusuhara, H
    Takadate, A
    Endou, H
    Otagiri, M
    Sugiyama, Y
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (01) : 162 - 174
  • [5] Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats
    Deguchi, T
    Nakamura, M
    Tsutsumi, Y
    Suenaga, A
    Otagiri, M
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2003, 24 (08) : 345 - 355
  • [6] Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney
    Deguchi, T
    Ohtsuki, S
    Otagiri, M
    Takanaga, H
    Asaba, H
    Mori, S
    Terasaki, T
    [J]. KIDNEY INTERNATIONAL, 2002, 61 (05) : 1760 - 1768
  • [7] Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat
    Hasegawa, M
    Kusuhara, H
    Endou, H
    Sugiyama, Y
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) : 1087 - 1097
  • [8] Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions
    Hasegawa, M
    Kusuhara, H
    Sugiyama, D
    Ito, K
    Ueda, S
    Endou, H
    Sugiyama, Y
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) : 746 - 753
  • [9] HOLLER M, 1977, BIOCHEM SOC T, V5, P243
  • [10] Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney
    Kusuhara, H
    Sugiyama, Y
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) : 43 - 54